Cardinal Health, Inc.

🇺🇸New York Stock Exchange
Back to all articles
Cardinal Health, Inc. stock analysis CAH overview
Somewhat Bullish +27

We're adding to our position in a stock that has gotten cheaper since earnings

🚀 Jim Cramer's Charitable Trust increased its holding in Cardinal Health (CAH) by purchasing 50 additional shares at approximately $199.

📉 The trade capitalizes on a post-earnings decline, though the report initially showed a revenue miss and $184 million in impairment charges for specific reporting units.

📈 Analyst confidence remains high, with many raising their fiscal year 2027 earnings per share estimates to $11.91 from about $11.60 prior to the release.

💰 The stock's valuation has become attractive, trading at roughly 16.5 times next twelve months' estimates compared to a high of around 20 times in early March.

🤝 Management and the analyst community maintain confidence in Cardinal Health's ability to grow earnings per share in the low-to-mid teens over the long term.

📊 Following this purchase, the trust's total holding increased to 525 shares, representing a portfolio weight of 2.75% up from 2.50%.

⏳ Trading for CNIBC subscribers follows specific rules, such as waiting 45 minutes after sending an alert or 72 hours if the stock was discussed on CNBC TV.

📝 The article includes standard disclaimers stating that information is subject to terms and conditions, with no fiduciary obligation or guaranteed outcomes.

Bullish Signals
  • The Charitable Trust is adding shares to its position in Cardinal Health (CAH) following a post-earnings price decline, increasing its holding to 525 shares at an attractive entry point of roughly $199.
  • Both management and the analyst community express confidence in Cardinal Health's ability to grow earnings per share in the low-to-mid teens over the long term, prompting many analysts to raise their fiscal year 2027 EPS estimate from $11.60 to $11.91 on FactSet.
  • The stock is trading at a mid-teens price-to-earnings multiple of roughly 16.5 times next 12 months estimates, which represents a significant discount compared to the approximately 20x earnings multiple seen in early March.
  • Analysts have raised their consensus earnings estimate for fiscal year 2027 despite a recent revenue miss and impairment charges, indicating strong upside potential in future growth projections.
Risk Factors
  • Cardinal Health missed revenue expectations in its fiscal 2026 third quarter report.
  • The company recorded $184 million in impairment charges specifically for its Navista and ION reporting units, impacting overall profitability.
  • Shares recently experienced a price decline following the earnings announcement, indicating short-term negative market sentiment.
Full Analysis
Jim Cramer's Charitable Trust is increasing its holdings in Cardinal Health (CAH) by purchasing 50 shares at approximately $199 per share. This transaction brings the trust's total ownership to 525 shares, raising the position's weight in the portfolio from 2.50% to 2.75%. The team is acquiring these shares following a decline in stock price after the company reported earnings for fiscal third quarter 2026. Management and analysts remain confident in Cardinal Health's long-term ability to grow earnings per share in the low-to-mid teens, despite missing revenue expectations and reporting $184 million in impairment charges for its Navista and ION reporting units. Consequently, many analysts have raised their fiscal year 2027 earnings per share estimates; the consensus on FactSet has increased from about $11.60 to $11.91 following the report. The negative price action combined with higher long-term earnings projections has made the stock appear significantly more attractive compared to one week ago. Current shares are trading at roughly 16.5 times the next twelve months' estimates, down from approximately 20 times earnings when the trust initially took its stake in early March. The CNBC Investing Club notes that Jim Cramer waits specific periods after issuing trade alerts before executing trades for his charitable trust, subject to standard terms and conditions with no fiduciary obligation or profit guarantee.